Company Description
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.
The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.
It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.
The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.
Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Country | United States |
Founded | 2022 |
IPO Date | Feb 21, 2025 |
Industry | Medical Distribution |
Sector | Healthcare |
Employees | 31 |
CEO | Brian Norton |
Contact Details
Address: 3000 Bayport Drive, Suite 950 Tampa, Florida 33607 United States | |
Phone | (844) 203-6092 |
Website | wellgisticshealth.com |
Stock Details
Ticker Symbol | WGRX |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.50 |
CIK Code | 0002030763 |
ISIN Number | US9495031067 |
Employer ID | 93-3264234 |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Tim Canning | Chief Executive Officer |
Vishnu Balu | Chief Financial Officer |
Chuck Wilson | Chief Operating Officer |
Dr. Shafaat Pirani | Chief Clinical Officer and Executive Vice President Healthcare Operations |
Brian Norton | Chief Commercial Officer |
Prashant Patel | Chief Strategy Officer and Vice Chairman of the Board |
Suren Ajjarapu | Chairman of the Board |
Sajid Syed | Director |
Donald W. Anderson | Director |
Rebecca Shanahan | Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2025 | 8-K | Current Report |
Mar 25, 2025 | 10-K | Annual Report |
Mar 21, 2025 | 8-K | Current Report |
Mar 6, 2025 | 424B3 | Prospectus |
Mar 6, 2025 | 8-K | Current Report |
Feb 28, 2025 | 8-K | Current Report |
Feb 26, 2025 | 8-K | Current Report |
Feb 21, 2025 | 424B4 | Prospectus |
Feb 20, 2025 | CERT | Certification by an exchange approving securities for listing |
Feb 18, 2025 | 8-A12B | Registration of securities |